Browse > Article

Effect of Antimicrobial Peptide from Coptidis Rhizoma on Candida albicans Infection  

Lee, Jue-Hee (School of Korean Medicine, Pusan University)
Publication Information
YAKHAK HOEJI / v.55, no.3, 2011 , pp. 227-233 More about this Journal
Abstract
We previously reported the protein isolated from Coptidis Rhizoma (CRP), which has antifungal activity against a fungal pathogen, Candida albicans. In the current study, we investigated what portion in the CRP is responsible for the antifungal activity. For the investigation, the CRP was fractionated on a Shepadex G-50 column. Data resulting from the fractionation, seven fractions were obtained. Fractions (Fr.) I, II, and III eluted initially from the column showed no inhibitory effect on the growth of C. albicans, whereas Fr. IV, V, and VI eluted later revealed inhibition of the growth, and Fr. IV and VI showed potent antifungal activity by broth susceptibility analysis. However, Fr. VI was contained in the CRP more than Fr. IV, which led us to select the VI for the following experiments. In a murine model of a subcutaneous candidiasis caused by C. albicans, the Fr. VI displayed a therapeutic effect on nude mice pretreated with anti-neutrophil monoclonal antibody (RB68C5) and then infected subcutaneously with live C. albicans. At day 16, these mice were healed almost up to 78% of the infected area when compared to infected area of control nude mice that received diluent (Dulbecco's Phosphate-Buffered Saline; DPBS), instead of the Fr. VI (P<0.01). The Fr. VI blocked hyphal formation from blastoconidial form of C. albicans (P<0.01), which might prevent penetration of hyphae to the deeper site of skin and thus helps the healing. In the ionic strength test, the effect of Fr. was influenced by $Ca^{2+}$ ion just like other known antimicrobial peptides, but the influence was affected at an extremely high concentration such as 500 mM. Thus, such ion-concentration is considered to be meaningless in the clinical situation. Considering all data together, Coptidis Rhizoma is appeared to produce an antimicrobial peptide that has therapeutic effect on subcutaneous infection caused by C. albicans.
Keywords
Coptidis Rhizoma protein (CRP); antimicrobial peptide; C. albicans; antifungal activity; RB68C5; subcutaneous candidiasis; ionic strength;
Citations & Related Records
Times Cited By KSCI : 2  (Citation Analysis)
연도 인용수 순위
1 Han, Y. and Cutler, J. E. : Assessment of a mouse model of neutropenia and the effect of an anti-candidiasis monoclonal antibody in these animals. J. Infect. Dis. 175, 1169 (1997).   DOI   ScienceOn
2 Han, Y. and Lee, J. H. : Berberine synergy with amphotericin B against disseminated candiasis in mice. Biol. Pharm. Bull. 28, 541 (2005).   DOI   ScienceOn
3 Villar, C. C., Kashleva, H. and Dongari-Bagtzoglou, A. : Role of Candida albicans polymorphism in interactions with oral epithelial cells. Oral Microbiol. Immunol. 19, 262 (2004).   DOI   ScienceOn
4 Vazquez-Torres, A. and Balish, E. : Macrophages in resistance to candidiasis. Microbiol. Mol. Biol. Rev. 61, 170 (1997).
5 Ashman, R. B. and Papadimitriou, J. M. : What's new in the mechanisms of host resistance to Candida albicans infection? Pathol. Res. Pract. 186, 527 (1990).   DOI   ScienceOn
6 Leberer, E., Ziegelbaue, R. K., Schmidt, A., Harcus, D., Dignard, D., Ash, J., Johnson, L. and Thomas, D. Y. : Curr. Biol. 7, 539 (1997).   DOI   ScienceOn
7 Phan, Q. T., Belanger, P. H. and Filler, S. G. : Role of hyphal formation in interactions of Candida albicans with endothelial cells. Infect. Immun. 68, 3485 (2000).   DOI   ScienceOn
8 Cutler, J. E., Granger, B. L. and Han, Y. : Vaccines, antibodies, and passive immunity in candidiasis. In: Fungal Pathogenesis. Principles and clinical application. (Ed) Calderone R. A. and Cihlar R. A. Marcel Dekker, Inc. New York. Mycology 14, 325 (2002).
9 Cutler, J. E. : Putative virulence factors of Candida albicans. Ann. Rev. Microbiol. 45, 187 (1991).   DOI   ScienceOn
10 Jutila, M. A., Kroese, F. G. M., Julita, K. L., et al. : Ly-6C is a monocyte/macrophage and endothelial cell differentiation antigen regulated by interferon-gamma. Eur. J. Immunol. 18, 1819 (1998).
11 Fleming, T. J., Fleming, M. L. and Malek, T. R. : Selective expression of Ly-6G on myeloid lineage cells in mouse bone marrow. RB6-8C5 Mab to granulocyte-differentiation antigen (Gr-1)detects members of the Ly-6 family. J. Immunol. 151, 2399 (1993).
12 Jutila, M. A., Kishimoto, T. K. and Finken, M. : Low-dose chymotrypsin treatment inhibits neutriohil migration into sites of inflammation in vivo: effects on Mac-1 and MEL-14 adhesion protein expression and function. Cell Immunol. 132, 201 (1991).   DOI   ScienceOn
13 Czuprynski, C. J., Brown, J. F., Maroushek, N., Wagner, R. D. and Steinberg, H. : Administration of anti-granulocyte mAb RB6-8C5 impairs the resistance of mice to Listeria monocytogenes infection. J. Immunol. 152, 1836 (1994).
14 Bulet, P., Stocklin, R. and Menin, L. : Anti-microbial peptides: from invertebrates to vertebrates. Immunol. Rev. 198, 169 (2004).   DOI   ScienceOn
15 Pekarek, L. A., Starr, B. A., Toledano, A. Y. and Schreiber, H. : Inhibition of tumor growth by elimination of granulocytes. J. Exp. Med. 181, 435 (1995).   DOI   ScienceOn
16 Desgagné-Penix, I., Khan, M. F., Schriemer, D. C., Cram, D., Nowak, J. and Facchini, P. J. : Integration of deep transcriptome and proteome analyses reveals the components of alkaloid metabolism in opium poppy cell cultures. BMC Plant Biol. 10, 252 (2010).   DOI
17 Dzik, J. M. : The ancestry and cumulative evolution of immune reactions. Acta Biochim. Pol. 57, 443 Epub (2010).
18 Zasloff, M. : Antimicrobial peptides of multicellular organisms. Nature 415, 389 (2002).   DOI   ScienceOn
19 Lee, D. G., Park, Y., Kim, H. N., Kim, H. K., Kim, P. I., Choi, B. H. and Hahm, K. S. : Antifungal mechanism of an antimicrobial peptide, HP (2--20), derived from N-terminus of Helicobacter pylori ribosomal protein L1 against Candida albicans. Biochem. Biophys. Res. Commun. 291, 1006 (2002).   DOI   ScienceOn
20 Fleury, Y., Dayem, M. A., Montagne, J. J., Chaboisseau, E., Le Caer, J. P., Nicolas, P. and Delfour, A. : Covalent structure, synthesis, and structure-function studies of mesentericin Y 105(37), a defensive peptide from gram-positive bacteria Leuconostoc mesenteroides. J. Biol. Chem. 271, 14421 (1996).   DOI
21 Brogden, K. A. : Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat. Rev. Microbiol. 3, 238 (2005).   DOI   ScienceOn
22 Broekaert, W. F., Terras, F. R., Cammue, B. P. and Osborn, R. W. : Plant defensins: novel antimicrobial peptides as components of the host defense system. Plant Physiol. 108, 1353 (1995).   DOI
23 Kim, H., Lee, J. H., Shim, J. K. and Han, Y. : Anticandidal activity of the protein substance from Coptidis Rhizoma. Yakhak Hoeji 49, 323 (2005).
24 Lee, J. H., Shim, J. K. and Han, Y. : Mode of action of Coptidis Rhizoma protein and its activity against subcutaneous candidiasis due to Candida albicans. Anticandidal activity of the protein substance from Coptidis Rhizoma. Yakhak Hoeji 49, 422 (2005).
25 Danilova, N. : The evolution of immune mechanisms. J. Exp. Zool. 306B, 496 (2006).   DOI   ScienceOn
26 Wisplinghoff, H., Bischoff, T., Tallent, S. M., Seifert, H., Wenzel, R. P. and Edmond, M. B. : Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin. Infect. Dis. 39, 309 (2004).   DOI   ScienceOn
27 Perfect, J. R. and Schell, W. A. : The new fungal opportunists are coming. Clin. Infect. Dis. 22, S112 (1996).   DOI